SeaStar Medical is trading 10.3% down at $3.31 ahead of its scheduled second-quarter 2026 financial results after market close on August 12, 2026.
- The company announced the report and investor call for 4:30 p.m. ET.
- No confirmed company-specific announcement explains the decline so far; broader markets are higher, suggesting pre-earnings caution rather than broad-market weakness.